A combined ANXA2-NDRG1-STAT1 gene signature predicts response to chemoradiotherapy in cervical cancer

BACKGROUND: A better understanding of locally advanced cervical cancer (LACC) is mandatory for further improving the rates of disease control, since a significant proportion of patients still fail to respond or undergo relapse after concurrent chemoradiation treatment (CRT), and survival for these p...

Descripción completa

Detalles Bibliográficos
Autores principales: Buttarelli, Marianna, Babini, Gabriele, Raspaglio, Giuseppina, Filippetti, Flavia, Battaglia, Alessandra, Ciucci, Alessandra, Ferrandina, Gabriella, Petrillo, Marco, Marino, Carmela, Mancuso, Mariateresa, Saran, Anna, Villani, Maria Elena, Desiderio, Angiola, D’Ambrosio, Chiara, Scaloni, Andrea, Scambia, Giovanni, Gallo, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595690/
https://www.ncbi.nlm.nih.gov/pubmed/31242951
http://dx.doi.org/10.1186/s13046-019-1268-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595690/
https://www.ncbi.nlm.nih.gov/pubmed/31242951
http://dx.doi.org/10.1186/s13046-019-1268-y

Ejemplares similares